Page last updated: 2024-10-16

carbamates and Retinal Degeneration

carbamates has been researched along with Retinal Degeneration in 6 studies

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research Excerpts

ExcerptRelevanceReference
"Calpains are activated by excessive light exposure and related to retinal degeneration."7.76Calpain inhibitor protects cells against light-induced retinal degeneration. ( Hara, H; Imai, S; Nakanishi, T; Shimazawa, M; Tsuruma, K, 2010)
"Our results suggested that orally available calpain inhibitor SNJ-1945 might be a possible candidate drug for testing in preventing progression of glaucomatous retinal degeneration."7.73Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. ( Azuma, M; Nakajima, E; Oka, T; Shearer, TR; Tamada, Y; Tochigi, A; Walkup, RD, 2006)
" One hour after ocular hypertension (OH), SNJ-1945 was administrated as a single oral dose of 50 mg/kg."3.80Degeneration and dysfunction of retinal neurons in acute ocular hypertensive rats: involvement of calpains. ( Azuma, M; Oka, T; Shearer, TR; Suzuki, R; Tamada, Y, 2014)
"Calpains are activated by excessive light exposure and related to retinal degeneration."3.76Calpain inhibitor protects cells against light-induced retinal degeneration. ( Hara, H; Imai, S; Nakanishi, T; Shimazawa, M; Tsuruma, K, 2010)
"Our results suggested that orally available calpain inhibitor SNJ-1945 might be a possible candidate drug for testing in preventing progression of glaucomatous retinal degeneration."3.73Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. ( Azuma, M; Nakajima, E; Oka, T; Shearer, TR; Tamada, Y; Tochigi, A; Walkup, RD, 2006)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suzuki, R1
Oka, T3
Tamada, Y2
Shearer, TR2
Azuma, M2
Shimazawa, M2
Suemori, S1
Inokuchi, Y1
Matsunaga, N1
Nakajima, Y1
Yamamoto, T1
Hara, H2
Imai, S1
Nakanishi, T1
Tsuruma, K1
NAKAMURA, GR1
Walkup, RD1
Nakajima, E1
Tochigi, A1
Pouliquen, Y1
Guyot-Argenton, C1

Other Studies

6 other studies available for carbamates and Retinal Degeneration

ArticleYear
Degeneration and dysfunction of retinal neurons in acute ocular hypertensive rats: involvement of calpains.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2014, Volume: 30, Issue:5

    Topics: Acute Disease; Animals; Calpain; Carbamates; Male; Ocular Hypertension; Rats; Rats, Sprague-Dawley;

2014
A novel calpain inhibitor, ((1S)-1-((((1S)-1-Benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945), reduces murine retinal cell death in vitro and in vivo.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:2

    Topics: Administration, Oral; Animals; Calpain; Carbamates; Cell Line; Cell Survival; Glycoproteins; Injecti

2010
Calpain inhibitor protects cells against light-induced retinal degeneration.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3

    Topics: Animals; Apoptosis; Calpain; Carbamates; Caspase 3; Caspase 7; Electroretinography; Light; Male; Mic

2010
The detection of 1-ethinyl cyciohexyl carbamate in toxicological specimens and its separation from a mixture of other drugs.
    Journal of the American Pharmaceutical Association. American Pharmaceutical Association, 1958, Volume: 47, Issue:5

    Topics: Carbamates; Humans; Hypnotics and Sedatives; Rare Diseases; Retinal Degeneration; Retinal Detachment

1958
Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester.
    Neuroscience, 2006, Sep-15, Volume: 141, Issue:4

    Topics: Animals; Calcium-Binding Proteins; Calpain; Carbamates; Disease Models, Animal; Drug Administration

2006
[Contribution of pyridinol-carbamate in ophthalmologic therapeutics].
    La Nouvelle presse medicale, 1972, Jan-15, Volume: 1, Issue:3

    Topics: Adult; Aged; Arteriosclerosis; Carbamates; Diabetic Retinopathy; Female; Humans; Male; Middle Aged;

1972